Gabapentin for the treatment of spasticity in patients with amyotrophic lateral sclerosis.
de Carvalho
M
M
D000085:Acetates / Q000627:therapeutic use*; D000368:Aged; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D016472:Motor Neuron Disease / Q000188:drug therapy*; D009128:Muscle Spasticity / Q000188:drug therapy*; D009460:Neurologic Examination / Q000187:drug effects; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin